Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 2,306.00
-19.00 (-0.82%)
At close: Aug 21, 2026
Glenmark Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Glenmark Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of ₹2,498. The average 1-year stock price forecast is 8.31% higher than the current stock price, while the lowest is ₹2,100 (-8.93%) and the highest is ₹2,750 (+19.25%).
Price Target: ₹2,498 (+8.31%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Glenmark Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 6 | 6 | 7 |
| Buy | 3 | 3 | 2 | 3 | 4 | 3 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 11 | 12 | 12 |
Financial Forecast
Revenue This Year
167.93B
from 169.83B
Decreased by -1.12%
Revenue Next Year
187.12B
from 167.93B
Increased by 11.43%
EPS This Year
79.99
from 103.32
Decreased by -22.58%
EPS Next Year
97.67
from 79.99
Increased by 22.10%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.